P. Potter

发表

Cholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition

T. Beach, D. Walker, M. Emmerling, 2000, Neuroscience Letters.

Cortical Cholinergic Denervation Elicits Vascular Aβ Deposition

W. Honer, T. Beach, D. Walker, 2000 .

Cortical Cholinergic Deafferentation Induces Aβ Deposition

W. Honer, T. Beach, D. Walker, 2005 .

Heterogeneity of presynaptic muscarinic receptors involved in modulation of transmitter release

E. Vizi, M. Kinjo, H. Nagashima, 1989, Neuroscience.

Phenytoin protects against hypoxia-induced death of cultured hippocampal neurons

P. Stanton, P. Potter, F. Boehm, 1994, Neuroscience Letters.

Lesion of septal-hippocampal neurons with 192 IgG-saporin alters function of M1 muscarinic receptors

P. Potter, C. Gaughan, Y. Assouline, 1999, Neuropharmacology.

Modulation of hippocampal norepinephrine release by cholinergic agonists is altered by AF64A lesion

P. Potter, C. Gaughan, B. Thorne, 1997, Brain Research Bulletin.

Lesion with the neurotoxin AF64A alters hippocampal cholinergic receptor function

P. Potter, B. Thorne, 1995, Brain Research Bulletin.

Alterations in modulation of acetylcholine release following lesion of hippocampal cholinergic neurons with the neurotoxin AF64A

P. Potter, S. Nitta, 1993, Neuropharmacology.

Chronic treatment with diisopropylfluorophosphate increases dopamine turnover in the striatum of the rat.

P. Potter, N. Neff, Maria Hadjiconstantinou, 1984, European journal of pharmacology.

Lack of effect of 6-hydroxydopamine pretreatment on depolarization-induced release of ATP fron rat brain synaptosomes.

P. Potter, T. White, 1982, European journal of pharmacology.

Anti‐amyloidogenic activity of cholinergic agents

T. Beach, D. Walker, A. Roher, 2002 .

Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13

P. Stanton, J. Moskal, P. Potter, 2009, Neuroreport.

Acetylcholine and Choline in Neuronal Tissue Measured by HPLC with Electrochemical Detection

J. Meek, P. Potter, N. Neff, 1983, Journal of neurochemistry.

Release of adenosine 5′-triphosphate from synaptosomes from different regions of rat brain

P. Potter, T. White, 1980, Neuroscience.

Tetrodotoxin-resistant release of ATP from guinea-pig taenia coli and vas deferens during electrical field stimulation in the presence of luciferin-luciferase.

G. Burnstock, P. Potter, C. Moody, 1981, Canadian journal of physiology and pharmacology.

Depolarisation‐Induced Release of ATP from Cortical Synaptosomes Is Not Associated with Acetylcholine Release

S. Wonnacott, P. Potter, T. White, 1980, Journal of neurochemistry.

Selective Cholinergic Neurotoxins

T. J. Walsh, P. Potter, 1998 .

Peripheral and central actions of AF64A (ethylcholine mustard aziridinium ion) on acetylcholine release, in vitro: Comparison with hemicholinium

E. Vizi, L. Hársing, P. Potter, 1985, Neurochemistry International.

Curcumin: a natural substance with potential efficacy in Alzheimer’s disease

P. Potter, 2013, Journal of experimental pharmacology.

Measurement of Acetylcholine Turnover Rate in Brain: An Adjunct to a Simple HPLC Method for Choline and Acetylcholine

J. Meek, P. Potter, N. Neff, 1984, Journal of neurochemistry.

Spinal cord acetylcholine content: the consequence of transection or treatment with the neurotoxin 6-aminonicotinamide

P. Potter, N. Neff, 1984, Brain Research.

Estimation of Acetylcholine and Choline and Analysis of Acetylcholine Turnover Rates In Vivo

P. Potter, I. Hanin, 1988 .

Investigational Medications for Treatment of Patients With Alzheimer Disease

P. Potter, 2010, The Journal of the American Osteopathic Association.

Localized changes in blood-brain barrier permeability following the administration of antineoplastic drugs.

R. Leslie, P. Potter, L. Macdonell, 1978, Cancer research.

Reduction of cerebrospinal fluid amyloid β after systemic administration of M1 muscarinic agonists

T. Beach, D. Walker, A. Fisher, 2001, Brain Research.

Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease

M. Sabbagh, T. Beach, D. Walker, 2011, Acta Neuropathologica.

Cortical Cholinergic Lesion Causes Aβ Deposition: Cholinergic-Amyloid Fusion Hypothesis

L. Lue, T. Beach, D. Walker, 2008 .

Effect of cholinergic deficit induced by ethylcholine aziridinium (AF64A) on noradrenergic and dopaminergic parameters in rat brain

P. Potter, I. Hanin, Heide Ho¨rtnagl, 1987, Brain Research.

Trans-synaptic modulation via muscarinic receptors of serotonin- containing small intensely fluorescent cells of superior cervical ganglion

P. Potter, N. Neff, Maria Hadjiconstantinou, 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Effect of cholinergic deficit induced by ethylcholine aziridinium on serotonergic parameters in rat brain

P. Potter, I. Hanin, H. Hörtnagl, 1987, Neuroscience.

Selective impairment of acetylcholine release and content in the central nervous system following intracerebroventricular administration of ethylcholine mustard aziridinium ion (AF64A) in the rat

E. Vizi, L. Hársing, P. Potter, 1986, Neurochemistry International.

Clonidine Prevents Transient Loss of Noradrenaline in Response to Cholinergic Hypofunction Induced by Ethylcholine Aziridinium (AF64A)

E. Singer, P. Potter, I. Hanin, 1989, Journal of neurochemistry.

Inhibition of high affinity choline transport attenuates both cholinergic and non-cholinergic effects of ethylcholine aziridinium (AF64A)

P. Potter, I. Hanin, C. Tedford, 1989, Brain Research.

Effects of intracerebroventricular AF64A administration on cholinergic, serotoninergic and catecholaminergic circuitry in rat dorsal hippocampus

E. Vizi, P. Potter, I. Hanin, 1986, Neuroscience.

Role of the aziridinium moiety in the in vivo cholinotoxicity of ethylcholine aziridinium ion (AF64A)

P. Potter, I. Hanin, H. Hörtnagl, 1988, Journal of Neuroscience Methods.

Noradrenaline depletion protects cholinergic neurons in rat hippocampus against AF64A-induced damage

P. Potter, I. Hanin, H. Hörtnagl, 1989, Journal of Neuroscience Methods.

Curcumin Offers Potential Efficacy for Treating Alzheimer’s Disease

P. Potter, 2019, Curcumin for Neurological and Psychiatric Disorders.

α 2A subtype of presynaptic α 2-Adrenoceptors modulates the release of [3H]-noradrenaline from rat spinal cord

E. Vizi, H. Nagashima, P. Potter, 1997, Brain Research Bulletin.

Branched-chain amino acid-induced hippocampal norepinephrine release is antagonized by picrotoxin: evidence for a central mode of action

D. Katz, P. Potter, K. Torigoe, 1999, Brain Research Bulletin.

Cortical cholinergic denervation elicits vascular A beta deposition.

W. Honer, T. Beach, D. Walker, 2000, Annals of the New York Academy of Sciences.

Narcoleptic orexin receptor knockout mice express enhanced cholinergic properties in laterodorsal tegmental neurons

C. Leonard, M. Yanagisawa, R. Chemelli, 2010, The European journal of neuroscience.

Immunotoxin Lesion of the Cholinergic Nucleus Basalis Causes Aβ Deposition: Towards a Physiologic Animal Model of Alzheimers Disease

T. Beach, D. Walker, M. Emmerling, 2003 .

Thiorphan-induced neprilysin inhibition raises amyloid β levels in rabbit cortex and cerebrospinal fluid

T. Beach, D. Walker, L. Sue, 2003, Neuroscience Letters.

Dopamine in the rat ventral pallidum/substantia innominata: Biochemical and electrophysiological studies

P. Potter, T. Napier, 1989, Neuropharmacology.

Diphenylhydantoin attenuates hypoxia-induced release of [3H]glutamate from rat hippocampal slices

J. Moskal, P. Potter, B. Thorne, 1991, Brain Research.